The costs for drug discovery and development are skyrocketing, but AI (artificial intelligence) is introducing new efficiencies to help find effective treatments faster.
A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million. Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most
Read More
dataset
Gradient AI Acquires Healthcare Analytics Business Unit from Prognos Health 
What You Should Know:
- Gradient AI, a leading enterprise software provider of artificial intelligence (AI) solutions in the insurance industry, recently announced that it has acquired Prognos Health’s analytics business underwriting unit to leverage data from the company’s large collection of integrated medical records and lab data via its real-world data marketplace.
- The acquisition will enable Gradient AI to expand its medical database capabilities by integrating Prognos Health’s data
Read More
New athenahealth Research Finds that Telehealth Fills Care Gaps
What You Should Know:
- Increased usage of telehealth, driven by COVID-19, not only remains substantially above pre-pandemic levels but has also emerged as both a key diagnostic tool and treatment vehicle, according to new research from athenahealth.
- The findings, announced today by athenahealth, a leading provider of network-enabled software and services for medical groups and health systems nationwide, suggest that telehealth is now integrated across the care continuum. The findings
Read More
ONC and HRSA Launches USCDI+ Initiative to Support UDS Modernization
What You Should Know:
- ONC and HRSA launches a new USCDI+ collaboration to support HRSA’s Uniform Data System (UDS) reporting through the UDS Modernization Initiative.
- Last October ONC announced USCDI+, an initiative to support the identification and establishment of domain or program-specific datasets that will operate as extensions to the existing USCDI. In particular, ONC envisioned USCDI+ as a service that ONC would provide to federal partners who have a
Read More
Realizing the Dream of AI in Clinical Trials—How to Address Key Challenges
The clinical development process is incredibly time consuming and only yields a success rate of about 10%. One way to reduce the time, cost and success of the clinical development process is to introduce artificial intelligence (AI) into clinical trials and implement AI-driven process automation.
The dream of AI in clinical trial execution is for trial functions to run autonomously, like a self-driving car. A self-driving car knows how fast it is going, where it needs to go,
Read More
Abridge Secures $12.5M to Power AI-Powered Medical Conversations
What You Should Know:
- Abridge, the leader in medical conversation artificial intelligence (AI), today announced an oversubscribed $12.5M Series A-1 led by Wittington Ventures.
- The round also had participation from all existing investors including Union Square Ventures, Bessemer Venture Partners, Pillar Venture Capital, and UPMC Enterprises, and new investors including Turing Award winner Yoshua Bengio, and Whistler Capital.
Automated Solutions to Combat Physician
Read More
Analysis: 2022 Semi-Annual Health IT Market Review
Executive Summary
Act III of COVID: Navigating the Crosscurrents of Post-Inflation
2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
Cornerstone AI Raises $5M to Solve Healthcare’s Data Problem
- Cornerstone AI, a new company solving healthcare’s data challenges to improve research and care, publicly launched its first-of-its-kind AI platform.
- The company also announced a $5M seed round led by Healthy Ventures. The funding marked the first investment for Initiate’s affiliated fund, Initiate Ventures. Healthy Ventures General Partner Anya Schiess and Initiate’s Rowan Chapman and lana Dimkova have joined Cornerstone’s board of directors. Funds will be used to further product
Read More
Tempus Launches Psychiatric Real-World Data Collaboration
What You Should Know:
- Tempus, an $8B precision medicine company, announced the launch of a new psychiatric real-world data program to leverage real-world data to inform mental health treatment.
- Tempus N+ is a collaboration between provider institutions across the country and Tempus to build an infrastructure for data-driven research – providers can seamlessly and securely contribute molecular and clinical data, and in turn, their clinicians and researchers can access a
Read More
3 Keys to Eliminating Data Breakdowns in Life Sciences
Across life sciences, experts boldly predict that data is the new currency—and that mobilizing data from clinical trials, wearable devices and even social media will ignite innovation in 2022. But leveraging data for innovation depends not just on data analytics, but also access to the right data and timely analysis.
As the amount of data that life sciences experts have at their fingertips explodes, with leaders tapping into real-world evidence from smartphone apps, wearable devices and
Read More
